Danisco Invests In WellGen
Danisco Venture, Copenhagen, Denmark, has made a strategic investment in U.S. start-up company WellGen, New Brunswick, NJ. WellGen is developing proprietary substances that, if successful, will contribute to reducing the risk of certain types of cancer. WellGen’s first product candidate is based on orange peel. The orange peel extract was developed for WellGen by Florida Flavors, a flavor house Danisco acquired in April 2001. Apart from discovering the extract’s impact on the prevention of colon cancer, other substances with a positive impact on cancer have been identified by WellGen.